Anpario (LON:ANP) Sets New 1-Year High – Here’s Why

Shares of Anpario plc (LON:ANPGet Free Report) hit a new 52-week high during trading on Monday . The company traded as high as GBX 460 ($5.59) and last traded at GBX 454.15 ($5.52), with a volume of 67520 shares traded. The stock had previously closed at GBX 458.89 ($5.58).

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group upped their target price on shares of Anpario from GBX 380 ($4.62) to GBX 500 ($6.08) and gave the company a “buy” rating in a research note on Tuesday, January 14th.

Check Out Our Latest Stock Analysis on ANP

Anpario Stock Performance

The company has a current ratio of 6.15, a quick ratio of 5.16 and a debt-to-equity ratio of 0.21. The firm has a market capitalization of £76.80 million, a price-to-earnings ratio of 2,523.06 and a beta of 0.58. The stock has a fifty day moving average price of GBX 370.03 and a 200-day moving average price of GBX 325.13.

Insider Buying and Selling at Anpario

In other news, insider Karen Prior sold 14,000 shares of Anpario stock in a transaction that occurred on Friday, December 13th. The shares were sold at an average price of GBX 380 ($4.62), for a total value of £53,200 ($64,704.45). Company insiders own 30.51% of the company’s stock.

Anpario Company Profile

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Featured Articles

Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.